A study looking at the impact of training doctors in how to respond to a patient questionnaire about quality of life (QuEST-T2)

Cancer type:

Bowel (colorectal) cancer
Breast cancer
Cervical cancer
Ovarian cancer
Vaginal cancer
Vulval cancer
Womb (uterine or endometrial) cancer





This study assessed the impact of a programme to train doctors in interpreting a patient quality of life questionnaire.

When this study was done, The Leeds Cancer Centre at St James’s University Hospital introduced a new way to find out what problems and concerns patients have about their cancer and treatment. Before seeing the doctor, patients filled in a brief quality of life questionnaire using a touch screen computer. The doctors saw the results of the questionnaire before seeing the patient.

The aim of this study was to assess the impact of a training programme. The programme was designed to help doctors interpret and use the information provided in the new quality of life questionnaires that patients were filling in.

Summary of results

The researchers found that a training session helped doctors to use the information provided in the new questionnaires.

The study involved 3 doctors and 60 patients who had breast cancer, bowel cancer or gynaecological cancers.

Before having an appointment with the doctor to talk about chemotherapy, the patients filled in a questionnaire using a touch screen computer. It included questions about symptoms and how they were feeling, as well as asking about their social and family life. The doctor was given information from the questionnaire to look at during the appointment.

After seeing 10 patients who had filled in these questionnaires, the doctors had a training session that lasted 3 to 4 hours. They then had appointments with 10 more patients who had filled in the questionnaires.

Audio recordings were made of the appointments so that the study team could see how the doctors were using information from the questionnaires both before and after the training session.

From listening to the recordings, the researchers suggest that after the training session, there was more discussion about issues such as pain.

The researchers concluded that a short training programme can help doctors to interpret and act on the information gathered in questionnaires filled in by patients.

We have based this summary on information from the team who ran the study. The information they sent us has been reviewed by independent specialists (peer reviewed Open a glossary item) and published in a medical journal. The figures we quote above were provided by the study team. We have not analysed the data ourselves.

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Professor Galina Velikova

Supported by

Cancer Research UK
NIHR Clinical Research Network: Cancer
The Leeds Teaching Hospitals NHS Trust
University of Leeds

Questions about cancer? Contact our information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:

Oracle 8786

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Around 1 in 5 people take part in clinical trials

3 phases of trials

Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.

Last reviewed:

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page